⌘K

Login Start Free

Home/Filings/4/A/0001213900-20-031871

4/A//SEC Filing

Kiaie Namvar 4/A

Accession 0001213900-20-031871

CIK 0001726711other

View on SEC.gov Company Profile

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 8:38 PM ET

Size

5.6 KB

Accession

0001213900-20-031871

Insider Transaction Report

Form 4/AAmended

Period: 2020-10-13

ADiTx Therapeutics, Inc.ADTX

Director

Transactions

Award
Stock Option (Right to Buy)
2020-10-13+10,000→ 10,000 total
Exercise: $1.94Exp: 2030-10-13→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020.

Documents

1 file

4
ownership.xml

Issuer

ADiTx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1

filerCIK 0001817639

Filing Metadata

Form type: 4/A
Filed: Oct 15, 8:00 PM ET
Accepted: Oct 16, 8:38 PM ET
Size: 5.6 KB

View on SEC.gov